Nurix Therapeutics EPS Diluted (Quarterly) Trends

Nurix Therapeutics Inc (NRIX)

22.05 -0.32 (-1.43%) USD | NASDAQ | Nov 22, 16:00

21.50 -0.55 (-2.49%) After-Hours: 20:00

EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2019. Upgrade now.

Date	Value
August 31, 2024	-0.67
May 31, 2024	-0.71
February 29, 2024	-0.76
November 30, 2023	-0.77
August 31, 2023	-0.68
May 31, 2023	-0.45
February 28, 2023	-0.75
November 30, 2022	-0.87
August 31, 2022	-0.90
May 31, 2022	-1.01
February 28, 2022	-0.95

Date	Value
November 30, 2021	-0.85
August 31, 2021	-0.65
May 31, 2021	-0.60
February 28, 2021	-0.63
November 30, 2020	-0.51
August 31, 2020	-1.09
May 31, 2020	0.00
February 29, 2020	-0.5963
November 30, 2019	-0.6506
August 31, 2019	-0.1168

Earnings per Share Definition

Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.

Read full definition.

EPS Diluted (Quarterly) Range, Past 5 Years

-1.09

Minimum

Aug 2020

Maximum

May 2020

-0.7048

Average

-0.695

Median

EPS Diluted (Quarterly) Benchmarks

Enzo Biochem Inc	-0.26
Neogen Corp	-0.06
Pfizer Inc	0.78
Zymeworks Inc	-0.39
Accolade Inc	-0.30

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly)	-48.96M
Revenue (Quarterly)	12.59M
Total Expenses (Quarterly)	67.20M
Enterprise Value	1.114B
Profit Margin (Quarterly)	-388.9%
Earnings Yield	-13.20%
Normalized Earnings Yield	-13.20